Empirical Finance’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.75M | Buy |
13,473
+431
| +3% | +$207K | 0.28% | 70 |
|
|
2026
Q1 | $6.41M | Sell |
13,042
-28
| -0.2% | -$15.2K | 0.3% | 67 |
|
|
2025
Q4 | $7.57M | Sell |
13,070
-973
| -7% | -$550K | 0.36% | 51 |
|
|
2025
Q3 | $6.81M | Buy |
14,043
+128
| +0.9% | +$59.6K | 0.32% | 58 |
|
|
2025
Q2 | $5.64M | Buy |
13,915
+489
| +4% | +$204K | 0.3% | 63 |
|
|
2025
Q1 | $6.68M | Buy |
13,426
+171
| +1% | +$92.6K | 0.4% | 42 |
|
|
2024
Q4 | $6.9M | Sell |
13,255
-175
| -1% | -$96.2K | 0.4% | 42 |
|
|
2024
Q3 | $8.31M | Buy |
13,430
+271
| +2% | +$160K | 0.48% | 35 |
|
|
2024
Q2 | $7.28M | Sell |
13,159
-984
| -7% | -$564K | 0.45% | 38 |
|
|
2024
Q1 | $8.22M | Buy |
14,143
+467
| +3% | +$262K | 0.5% | 37 |
|
|
2023
Q4 | $7.26M | Buy |
13,676
+70
| +0.5% | +$33.9K | 0.51% | 39 |
|
|
2023
Q3 | $6.89M | Buy |
13,606
+1,259
| +10% | +$671K | 0.51% | 37 |
|
|
2023
Q2 | $6.44M | Buy |
12,347
+1,440
| +13% | +$777K | 0.5% | 38 |
|
|
2023
Q1 | $6.29M | Buy |
10,907
+470
| +5% | +$265K | 0.59% | 32 |
|
|
2022
Q4 | $5.75M | Buy |
10,437
+861
| +9% | +$456K | 0.6% | 34 |
|
|
2022
Q3 | $4.86M | Buy |
9,576
+1,568
| +20% | +$878K | 0.58% | 34 |
|
|
2022
Q2 | $4.35M | Buy |
8,008
+429
| +6% | +$236K | 0.55% | 34 |
|
|
2022
Q1 | $4.48M | Buy |
7,579
+810
| +12% | +$465K | 0.5% | 35 |
|
|
2021
Q4 | $4.52M | Buy |
6,769
+1,794
| +36% | +$1.12M | 0.53% | 29 |
|
|
2021
Q3 | $2.84M | Buy |
4,975
+274
| +6% | +$150K | 0.43% | 36 |
|
|
2021
Q2 | $2.37M | Buy |
4,701
+640
| +16% | +$302K | 0.39% | 46 |
|
|
2021
Q1 | $1.89M | Hold |
4,061
| – | – | 0.33% | 81 |
|
|
2020
Q4 | $1.89M | Buy |
4,061
+712
| +21% | +$334K | 0.33% | 81 |
|
|
2020
Q3 | $1.48M | Buy |
3,349
+690
| +26% | +$285K | 0.32% | 86 |
|
|
2020
Q2 | $963K | Buy |
2,659
+331
| +14% | +$111K | 0.25% | 109 |
|
|
2020
Q1 | $660K | Buy |
2,328
+833
| +56% | +$263K | 0.21% | 110 |
|
|
2019
Q4 | $486K | Buy |
1,495
+554
| +59% | +$168K | 0.12% | 139 |
|
|
2019
Q3 | $274K | Buy |
941
+19
| +2% | +$5.44K | 0.08% | 145 |
|
|
2019
Q2 | $271K | Sell |
922
-16
| -2% | -$4.41K | 0.07% | 138 |
|
|
2019
Q1 | $257K | Buy |
+938
| New | +$233K | 0.07% | 150 |
|
|
2018
Q2 | – | Sell |
-938
| Closed | -$257K | – | 189 |
|
|
2018
Q1 | $257K | Buy |
+938
| New | +$197K | 0.07% | 150 |
|
|
2017
Q4 | – | Sell |
-1,171
| Closed | -$222K | – | 148 |
|
|
2017
Q3 | $222K | Buy |
+1,171
| New | +$212K | 0.08% | 126 |
|
|
2017
Q1 | – | Sell |
-175
| Closed | -$25K | – | 526 |
|
|
2016
Q4 | $25K | Buy |
+175
| New | +$25.8K | 0.02% | 175 |
|
Other funds holding TMO
Empirical Finance's TMO Position: Q2 2026 in Review
Empirical Finance increased its Thermo Fisher Scientific (TMO) stake by 3.3% in Q2 2026, buying an estimated $207K and bringing the position to 13,473 shares worth $6.75M. The position accounts for 0.28% of the portfolio, ranked #70.
Empirical Finance first reported a position in TMO in Q4 2016 and has held it in 33 quarters since. The position peaked at $8.31M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Empirical Finance held 13,473 shares of Thermo Fisher Scientific worth $6.75M as of Q2 2026.
- Empirical Finance bought 431 Thermo Fisher Scientific shares in Q2 2026, an estimated $207K.
- Thermo Fisher Scientific made up 0.28% of Empirical Finance's portfolio in Q2 2026, its #70 holding.
- Empirical Finance first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 33 quarters since.
- Empirical Finance's Thermo Fisher Scientific position peaked at $8.31M in Q3 2024.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Empirical Finance's 13F filing for Q2 2026, filed 14 Aug 2026.